Aphria Inc. (TSX:APHA) Disappoints: Is the Stock Price Attractive Today?

I have long written about the problem with cannabis stocks and their valuations and the expectations that are built into them. I’ve also written about the strong likelihood that higher-than-expected spending, shareholder dilution, and slower-than-expected revenue growth will likely be very detrimental to stock prices. The industry, cycle, and growth are in their early stages. Aphria (TSX:APHA)(NYSE:APHA) reported its third-quarter…

Read More

3 Takeaways From Aphria Inc’s (TSX:APHA) Q3 Results

Aphria (TSX:APHA)(NYSE:APHA) released its third-quarter results on Monday. The company’s revenues were up more than 600% in what was its first quarter with a full three months of recreational sales. However, with Aphria recording a loss of more than $108 million, investors were left unimpressed, as the stock dropped 14% on the day the results were announced. It was a…

Read More

3 Ways Canopy Growth Corp (TSX:WEED) Is Overvalued

Recently, I wrote about weed company Aphria’s ambitious $1 billion sales target and the difficulty of hitting that goal. This time, I heard a similar tune from Canopy Growth (TSX:WEED)(NYSE:CGC). Being the largest publicly traded weed stock in the world, the goal of $1 billion net revenue is not ill-conceived. However, despite the $18.9 billion market cap and industry leader…

Read More

Which Pot Stock Should You Buy: Aphria Inc (TSX:APHA) or Green Organic Dutchman Holdings Ltd (TSX:TGOD)?

If you invested in a cannabis company last year, you likely made an impressive return. As the stock market caught up to the rapidly growing marijuana industry, nearly every pot stock rose considerably. Today, nearly a dozen cannabis stocks have market valuations in excess of $1 billion. In many ways, the incredible bargains of yesterday are gone. To succeed as…

Read More

Warning: Steer Clear of Aurora Cannabis Inc. (TSX:ACB) Stock

Two big news items this week have caught the attention of cannabis investors. The first is that Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) and Aphria Inc. (TSX:APHA)(NYSE:APHA) have been awarded contracts by the German government to cultivate and distribute medical marijuana throughout the country. This is clearly a big win, as it validates both cannabis companies and the quality of their medical…

Read More

Should You Buy Aphria Inc. (TSX:APHA) Stock Ahead of Earnings?

Aphria (TSX:APHA)(NYSE:APHA) is a heavyweight cannabis producer based in Ontario. Shares of Aphria fell 1.04% on April 8. The stock has climbed 69% in 2019 so far. Aphria stock surged above the $14 mark in early February on the back of significant internal shifts in the company and a broad move up for the cannabis sector. Back in early February,…

Read More

Aurora Cannabis (TSX:ACB) and Aphria (TSX:APHA) Get a Leg Up on the Competition

captor capital

Fort the most part, marijuana stocks have been bid up for one reason: the legalization of recreational marijuana in Canada. Pot stocks have sky-high valuations, and at the moment, their success as investments is dependent on this recreational demand. Lost amid the recreational hype is medical marijuana. Most pot stocks got their start as licensed medical marijuana producers. Major players,…

Read More

Is Aphria Inc.’s (TSX:APHA) $1 Billion Sales Target Out of Reach?

The norm these days for cannabis companies is to shore up investor interest with outlandish promises. Aphria (TSX:APHA)(NYSE:APHA) is the latest to make such pronouncement. But are investors ready to take the company’s target of $1 billion sales seriously? No one wants to see their money go up in smoke anymore. Last year was a horrific year for Aphria. A…

Read More

Could Aphria Inc (TSX:APHA) Beat Analyst Revenue Estimates in its Upcoming Earnings Report?

Leading Canadian marijuana firm Aphria (TSX:APHA)(NYSE:APHA) is set to release its fiscal third-quarter (Q3 2019) financial results for the period ended February 28 on April 15 before market open. Revenue growth and operating cost management remain the key investor focus right now and there is a strong chance that the company could surpass current analyst top-line projections in the upcoming…

Read More

Aphria Inc (TSX:APHA) Gets the Green Light for Expansion: Should You Buy the Stock?

If any Canadian marijuana producer has had a wild ride over the past year, it would have to be Aphria (TSX:APHA)(NYSE:APHA). After a fourth quarter of 2018 that included short attacks, lawsuits, and a hostile takeover bid, the company entered 2019 with a major management shakeup that fundamentally transformed the company. For months afterward, it was all quiet on the Aphria…

Read More